Mitochondrial DNA in human malignancy

Mutation Research - Reviews in Mutation Research

Volumn 488, Issue 2, 2001, Pages 119-133

  Penta, John S ^a   Johnson, F M ^a   Wachsman, Joseph T ^a   Copeland, William C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cancer; Mitochondrial disease; Mitochondrial DNA mutations; Reactive oxygen species (ROS)

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS DNA; GENE PRODUCT; MITOCHONDRIAL DNA; POLYPEPTIDE; REACTIVE OXYGEN METABOLITE;

BREAST CARCINOMA; CANCER CELL; CARCINOGENESIS; CELL ENERGY; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; DISEASE PREDISPOSITION; DNA REPAIR; GENE REPLICATION; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GENOME; HEAD AND NECK TUMOR; HEMATOLOGIC DISEASE; HUMAN; INTRON; LIVER CARCINOMA; LUNG TUMOR; MUTATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RESPIRATORY CHAIN; REVIEW; RNA TRANSLATION;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; LEUKEMIA; LIVER NEOPLASMS; LYMPHOMA; MALE; MUTATION; NEOPLASMS; REACTIVE OXYGEN SPECIES; STOMACH NEOPLASMS;

EID: 0035003072     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(01)00053-9     Document Type: Review

References (134)

1. Larsson N.-G., Clayton D.A. Molecular genetic aspects of human mitochondrial disorders. Annu. Rev. Genetics. 29:1995;151-178.
2. Chinnery P.F., Turnbull D.M. Mitochondrial DNA and disease. Lancet. 354:1999;17-21.
3. Yakes F.M., Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 94:1997;514-519.
4. Marcelino L.A., Thilly W.G. Mitochondrial mutagenesis in human cells and tissues. Mutat. Res. 434:1999;177-203.
5. M.K. Fliss, H. Usadel, O.L. Cabellero, et al., Facile detection of mitochondrial DNA mutations in tumors and bodily fluids, Science 287 (2000) 2017-2019.
6. Bianchi M.S., Bianchi N.O., Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet. Cell Genet. 71:1995;99-103.
7. K. Polyak, Y. LI, H. Zhu, et al., Somatic mutations of the mitochondrial genome in human colorectal tumours, Nature Genet. 20 (1998) 291-293.
8. T.H. Horton, J.A. Petros, A. Heddi, et al., Novel mitochondrial DNA deletion found in a renal cell carcinoma, Genes, Chromosomes Cancer 15 (1996) 95-101.
9. Luciakova K., Kuzela S. Increased steady-state levels of several mitochondrial and nuclear gene transcripts in rat hepatoma with a low content of mitochondria. Eur. J. Biochem. 205:1992;1187-1193.
10. G. Tamura, S. Nishizuka, C. Maesawa, et al., Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients, Eur. J. Cancer 35 (1999) 316-319.
11. Clayton D.A., Vinograd J. Circular dimer and catenate forms of mitochondrial DNA in human leukaemic leucocytes. Nature. 216:1967;652-657.
12. R.A. LaBiche, M. Yoshida, G.E. Gallick, et al., Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma, J. Cell. Biochem. 36 (1988) 393-403.
13. S. Toyokuni, K. Okamoto, J. Yodoi, et al., Persistent oxidative stress in cancer, FEBS Lett. 358 (1995) 1-3.
14. Wei Y.-H. Oxidative stress and mitochondrial DNA mutations in human aging. Proc. Soc. Exp. Biol. Med. 217:1998;53-63.
15. S. Anderson, A.T. Bankier, B.G. Barrell, et al., Sequence and organization of the human mitochondrial genome, Nature 290 (1981) 457-465.
16. Taanman J.-W. The mitochondrial genome: transcription, translation and replication. Biochim. Biophys. Acta. 1410:1999;103-123.
17. Wallace D.C. Mitochondrial DNA in aging and disease. Scientific Am. 277:1997;40-47.
18. Singh G., Sharkey S.M., Moorehead R. Mitochondrial DNA damage by anticancer agents. Pharmac. Ther. 54:1992;217-230.
19. Wei Y.-H. Mitochondrial DNA alterations as ageing-associated molecular events. Mutat. Res. 275:1992;145-155.
20. M. Unseld, J.R. Marienfeld, P. Brandt, et al., The mitochondrial genome of Arabidopsis thaliana contains 57 genes in 366,924 nucleotides, Nature Genet. 15 (1997) 57-61.
21. Palmer J.D. The mitochondrion that time forgot. Nature. 387:1997;454-455.
22. Wallace D.C. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61:1992;1175-1212.
23. Grossman L.I. Mitochondrial mutations and human disease. Environ. Mol. Mutagen. 25(Suppl. 26):1995;30-37.
24. Larsson N.-G., Luft R. Revolution in mitochondrial medicine. FEBS Lett. 455:1999;199-202.
25. Grossman L.I., Shoubridge E.A. Mitochondrial genetics and human disease. BioEssays. 18:1996;983-991.
26. H.T. Jacobs, I.J. Holt, The mitochondrial genetic system, in: K.K. Singh (Ed.) Mitochondrial DNA Mutations in Aging, Disease and Cancer, Springer, 1998, pp. 43-83.
27. H. Weiss, T. Friedrich, G. Hofhaus, et al., The respiratory-chain NADH dehydrogenase (Complex I) of mitochondria, Eur. J. Biochem. 197 (1991) 563-576.
28. Sherratt E.J., Thomas A.W., Alcolado J.C. Mitochondrial DNA defects: a widening clinical spectrum of disorders. Clin. Sci. 92:1997;225-235.
29. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Ann. Rev. Biochem. 54:1985;1015-1069.
30. Luft R., Landau B.R. Mitochondrial medicine. J. Internal Med. 238:1995;405-421.
31. Attardi G., Schatz G. Biogenesis of mitochondria. Ann. Rev. Cell Biol. 4:1988;289-333.
32. Robinson B.H. Human Complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim. Biophys. Acta. 1364:1998;271-286.
33. Clayton D.A. Replication of animal mitochondrial DNA. Cell. 28:1982;693-705.
34. Howell N. Human mitochondrial diseases: answering questions and questioning answers. Int. Rev. Cytol. 186:1999;49-116.
35. S. Lutz, H.-J. Weisser, J. Heizmann, et al., A third hypervariable region in the human mitochondrial D-loop, Human Genet. 101 (1997) 384.
36. M.G.F. Sharp, S.M. Adams, R.A. Walker, et al., Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue, J. Pathol. 168 (1992) 163-168.
37. S.M. Richard, G. Bailliet, G.L. Paez, et al., Nuclear and mitochondrial genome instability in human breast cancer, Cancer Res. 60 (2000) 4231-4237.
38. A. Alonso, P. Martin, C. Albarran, et al., Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis, Electrophoresis 18 (1997) 682-685.
39. B.G. Heerdt, J. Chen, L.R. Stewart, et al., Polymorphisms, but lack of mutations or instability, in the promoter region of the mitochondrial genome in human colonic tumors, Cancer Res. 54 (1994) 3912-3915.
40. Habano W., Nakamura S., Sugai T. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene. 17:1998;1931-1937.
41. W. Habano, T. Sugai, T. Yoshida, et al., Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability, Int. J. Cancer 83 (1999) 625-629.
42. X. Lu, T. Walker, J.P. MacManus, et al., Differentiation of HT-29 human colonic adenocarcinoma cells correlates with increased expression of mitochondrial RNA: effects of trehalose on cell growth and maturation, Cancer Res. 52 (1992) 3718-3725.
43. K.A. Chester, L. Robson, R.H.J. Begent, et al., In situ and slot hybridization analysis of RNA in colorectal tumors and normal colon shows distinct distributions of mitochondrial sequences, J. Pathol. 162 (1990) 309-315.
44. Savre-Train I., Piatyszek M.A., Shay J.W. Transcription of deleted mitochondrial DNA in human colon adenocarcinoma cells. Human Mol. Genet. 1:1992;203-204.
45. Yamamoto A., Horai S., Yuasa Y. Increased level of mitochondrial gene expression in polyps of familial polyposis coli patients. Biochem. Biophys. Res. Commun. 159:1989;1100-1106.
46. V. Maximo, P. Soares, R. Seruca, et al., Comments on: mutations in mitochondial control region DNA in gastric tumors of Japanese patients, Eur. J. Cancer 35 (1999) 1407-1408.
47. L.J. Burgart, J. Zheng, Q. Shu, et al., Somatic mitochondrial mutation in gastric cancer, Am. J. Pathol. 147 (1995) 1105-1111.
48. M. Corral, B. Paris, G. Baffet, et al., Increased level of the mitochondrial ND5 transcript in chemically-induced rat hepatomas, Exp. Cell Res. 184 (1989) 158-166.
49. H. Yamamoto, M.Tanaka, M. Katayama, et al., Significant existence of deleted mitochondrial DNA in cirrhotic liver surrounding hepatic tumor, Biochem. Biophys. Res. Commun. 182 (1992) 913-920.
50. Selvanayagam P., Rajaraman S. Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma. Lab. Invest. 74:1996;592-599.
51. Clayton D.A., Vinograd J. Complex mitochondrial DNA in leukemic and normal human myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 62:1969;1077-1084.
52. Clayton D.A., Smith C.A. Complex mitochondrial DNA. Int. Rev. Exp. Pathol. 14:1975;1-67.
53. D.L. Robberson, M.L. Gay, C.E. Wilkins, Genetically altered human mitochondrial DNA and a cytoplasmic view of malignant transformation, in: F.E. Arrighi, P.N. Rao, E. Stubblefield (Eds.), Genes, Chromosomes and Neoplasia, 1981, pp. 125-156.
54. Gattermann N. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leukemia Res. 24:1999;141-151.
55. LaBiche R.A., Demars M., Nicolson G.L. Transcripts of the mitochondrial gene ND5 are overexpressed in highly metastatic murine large cell lymphoma cells. In Vivo. 6:1992;317-324.
56. H.R. Schumacher, I.E. Szelkely, S.B. Patel, et al., Mitochondria: a clue to oncogenesis? Lancet 8 (11) (1973) 327.
57. Wilkie D., Egilsson V., Evans I.H. Mitochondria in oncogenesis. Lancet. 3(22):1975;697-698.
58. Hoberman H.D. Is there a role for mitochondrial genes in carcinogenesis? Cancer Res. 35:1975;3332-3335.
59. Pedersen P.L. Tumor mitochondria and the bioenergenetics of cancer cells. Prog. Exp. Tumor Res. 22:1978;190-274.
60. Shay J.W., Werbin H. Are mitochondrial DNA mutations involved in the carcinogenic process? Mutat. Res. 186:1987;149-160.
61. Richter C. Do mitochondrial DNA fragments promote cancer and aging? FEBS Lett. 241:1988;1-5.
62. Bandy B., Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Rad. Biol. Med. 8:1990;523-539.
63. Baggetto L.G. Role of mitochondria in carcinogenesis. Eur. J. Cancer. 29A:1993;156-159.
64. Shay J.W., Werbin H. New evidence for the insertion of mitochondrial DNA into the human genome: significance for cancer and aging. Mutat. Res. 275:1992;227-235.
65. Cavelli L.R., Liang B.C. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat. Res. 398:1998;19-26.
66. Neubert D., Hopfenmuller W., Fuchs G. Manifestation of carcinogenesis as a stochastic process on the basis of an altered mitochondrial genome. Arch. Toxicol. 48:1981;89-125.
67. Hartung J. Might cancer be a failed response to renegade mitochondria? J. Theoretical Biol. 94:1982;173-178.
68. Salazar J.J., Van Houten B. Preferential mitochondrial DNA injury caused by glucose oxidase as a steady generator of hydrogen peroxide in human fibroblasts. Mutat. Res. 385:1997;139-149.
69. T.H. Zastawny, M. Dabrowska, T. Jaskolski, et al., Comparison of oxidative base damage in mitochondrial and nuclear DNA, Free Rad. Biol. Med. 24 (1998) 722-725.
70. K. Khrapko, H.A. Coller, P.C. Andre, et al., Mitochondrial mutational spectra in human cells and tissues, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13798-13803.
71. Wang E., Wong A., Cortopassi G. The rate of mitochondrial mutagenesis is faster in mice than in humans. Mutat. Res. 377:1997;157-166.
72. Sohal R.S. Mitochondria generate superoxide anion radicals and hydrogen peroxide. FASEB J. 11:1997;1269-1270.
73. C. Richter, V. Gogvadze, R. Laffranchi, et al., Oxidants in mitochondria: from physiology to diseases, Biochim. Biophys. Acta 1271 (1995) 67-74.
74. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Rad. Biol. Med. 26:1999;463-471.
75. A. Boveris, S. Llesuy, L.A. Azzalis, et al., In situ rat brain and liver spontaneous chemiluminescence after acute ethanol intake, Toxicol. Lett. 93 (1997) 23-28.
76. Johns D.R. The other human genome: mitochondrial DNA and disease. Nature Med. 2:1996;1065-1068.
77. Sawyer D.E., Van Houten B. Repair of DNA damage in mitochondria. Mutat. Res. 434:1999;161-176.
78. M.J. Longley, R. Prasad, D.K Srivastava, et al., Identification of 5′-deoxyribose phosphate lyase activity in human DNA polymerase gamma and its role in mitochondrial base excision repair in vitro, Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 12244-12248.
79. Pinz K.G., Bogenhagen D.F. Efficient repair of abasic sites in DNA by mitochondrial enzymes. Mol. Cell. Biol. 18:1998;1257-1265.
80. Driggers W.J., LeDoux S.P., Wilson G.L. Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. J. Biol. Chem. 268:1993;22042-22045.
81. M. Ryoji, H. Katayama, H. Fusamae, et al., Repair of DNA damage in a mitochondrial lysate of Xenopus laevis oocytes, Nucleic Acids Res. 24 (1996) 4057-4062.
82. B. Pascucci, A. Versteegh, A. van Hoffen, et al., DNA repair of UV-photoproducts and mutagenesis in human mitochondrial DNA, J. Mol. Biol. 273 (1997) 417-427.
83. Croteau D.L., Bohr V.A. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272:1997;25409-25412.
84. Croteau D.L., Stierum R.H., Bohr V.A. Mitochondrial DNA repair pathways. Mutat. Res. 434:1999;137-148.
85. S.P. LeDoux, W.J. Driggers, B.S. Hollensworth, et al., Repair of alkylation and oxidative damage in mitochondrial DNA, Mutat. Res. 434 (1999) 149-159.
86. Bohr V.A., Dianov G.L. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie. 81:1999;155-160.
87. S.P. LeDoux, G.L. Wilson, E.J. Beecham, et al., Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells, Carcinogenesis 13 (1992) 1967-1973.
88. Kunkel T.A., Soni A. Exonucleolytic proof reading enhances the fidelity of DNA synthesis by chick embryo DNA polymerase-gamma. J. Biol. Chem. 263:1988;4450-4459.
89. Minnick D.T., Kunkel T.A. DNA synthesis errors, mutators and cancer. Cancer Surveys. 28:1996;3-20.
90. M.J. Longley, T.A. Kunkel, W.C. Copeland, in preparation.
91. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim. Biophys. Acta. 1271:1995;177-189.
92. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad. Biol. Medicine. 18:1995;775-794.
93. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:1991;794-798.
94. A.A. Konstantinov, A.V. Peskin, E.Yu. Popova, et al., Superoxide generation by the respiratory chain of tumor mitochondria, Biochim. Biophys. Acta 894 (1987) 1-10.
95. A. Dorward, S. Sweet, R. Moorehead, et al., Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance, J. Bioenergenetics Biomembr. 29 (1997) 385-392.
96. Richter C. Oxidative damage to mitochondrial DNA and its relationship to aging. Int. J. Biochem. Cell Biol. 27:1995;647-653.
97. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. U.S.A. 91:1994;10771-10778.
98. Wachsman J.T. The beneficial effects of dietary restriction: reduced oxidative damage and enhanced apoptosis. Mutat. Res. 350:1996;25-34.
99. Gille J.J.P., Joenje H. Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat. Res. 275:1992;405-414.
100. Y. Zhang, O. Marcillat, C. Giulivi, et al., The oxidative inactivation of mitochondrial electron transport chain components and ATPase, J. Biol. Chem. 265 (1990) 16330-16336.
101. S. Miranda, R. Foncea, J. Guerrero, et al., Oxidative stress and up-regulation of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells, Biochem. Biophys. Res. Commun. 258 (1999) 44-49.
102. Flury F., von Borstel R.C., Williamson D.H. Mutator activity of petite strains of Saccharomyces cerevisiae. Genetics. 83:1976;645-653.
103. S. Melov, P. Coskun, M. Patel, et al., Mitochondrial disease in superoxide dismutase-2 mutant mice, Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 846-851.
104. N.-G. Larrson, J. Wang, H. Wilhelmson, et al., Mitochondrial transcription factor A is necessary for mitochondrial DNA maintenance and embryogenesis in mice, Nature Genet. 18 (1998) 231-236.
105. Davies K.J.A. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUMB Life. 48:1999;41-47.
106. A. Heddi, G. Stepien, P.J. Benke, et al., Coordinate induction of energy gene expression in tissues of mitochondrial disease patients, J. Biol. Chem. 274 (1999) 22968-22976.
107. A. Torroni, G. Stepien, J.A. Hodge, et al., Neoplastic transformation is associated with coordinate induction of nuclear and cytoplasmic oxidative phosphorylation genes, J. Biol. Chem. 265 (1990) 20589-20593.
108. O. Warburg, The Metabolism of Tumors, London Constable Co. Ltd., 1930.
109. Nakashima R.A., Paggi M.G., Pedersen P.L. Contributions of glycolysis and oxidative phosphorylation to adenosine 5′-triphosphate production in AS-30D hepatoma cells. Cancer Res. 44:1984;5702-5706.
110. Mathupala S.P., Rempel A., Pedersen P.L. Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J. Biol. Chem. 270:1995;16918-16925.
111. M.M. Katabi, H.L.B. Chan, S.E. Karp, et al., Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells, Human Gene Ther. 10 (1999) 155-164.
112. Penso J., Beitner R. Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur. J. Pharmacol. 342:1998;113-117.
113. Sweet S., Singh G. Changes in mitochondrial mass, membrane potential, and cellular adenosine triphosphate content during the cell cycle of human leukemic (HL-60) cells. J. Cell. Physiol. 180:1999;91-96.
114. C. Van den Bogert, P. Muus, C. Haanen, et al., Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells, Exp. Cell Res. 178 (1988) 143-153.
115. Sweet S., Singh G. Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res. 55:1995;5164-5167.
116. Li K., Neufer P., Williams R.S. Nuclear responses to depletion of mitochondrial DNA in human cells. Am. J. Physiol. 269:1995;C1265-C1270.
117. R. Morais, K. Zinkewich-Peotti, M. Parent, et al., Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA, Cancer Res. 54 (1994) 3889-3896.
118. J.-I. Hayashi, S. Ohta, A. Kikuchi, et al., Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10614-10618.
119. 0) yield insight into physiological mechanisms. FEBS Lett. 454:1999;173-176.
120. Cavalli L.R., Varella-Garcia M., Liang B.C. Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differentiation. 8:1997;1189-1198.
121. Hayashi J.-I., Takemitsu M., Nonaka I. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somatic Cell Mol. Genet. 18:1992;123-129.
122. D.G. Murdock, B.E. Boone, L.A. Esposito, et al., Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator, J. Biol. Chem. 274 (1999) 14429-14433.
123. Glaichenhaus N., Leopold P., Cuzin F. Increased levels of mitochondrial gene expression in rat fibroblast cells immortalized or transformed by viral and cellular oncogenes. EMBO J. 5:1986;1261-1265.
124. M. Corral, G. Baffet, A. Kitzis, et al., DNA sequences homologous to mitochondrial genes in nuclei from normal rat tissues and from rat hepatoma cells, Biochem. Biophys. Res. Commun. 162 (1989) 258-264.
125. Liang B.C. Evidence for association of mitochondrial DNA sequence amplification and nuclear localization in human low-grade gliomas. Mutat. Res. 354:1996;27-33.
126. J. Boultwood, C. Fidler, K.I. Mills, et al., Amplification of mitchondrial DNA in acute myeloid leukaemia, Br. J. Haematol. 95 (1996) 426-431.
127. M.N. Gadaleta, G. Rainaldi, A.M.S. Lezza, et al., Mitochondrial DNA copy number and mitochondrial DNA deletion in adult and senescent rats, Mutat. Res. 275 (1992) 181-193.
128. V. Petruzzella, F. Fracasso, M.N. Gadaleta, et al., Age-dependent structural variations in rat brain mitochondrial DNA, Ann. N. Y. Acad. Sci. 673 (1992) 194-199.
129. A. Barrientos, J. Casademont, F. Cardellach, et al., Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA in human brain with aging, Brain Res. Mol. Brain Res. 52 (1997) 284-289.
130. H.C. Lee, P.H. Yin, C.Y. Lu, et al., Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells, Biochem. J. 348 (2) (2000) 425-432.
131. Barazzoni R., Short K.R., Nair K.S. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J. Biol. Chem. 275:2000;3343-3347.
132. Reid R.A. Can migratory mitochondrial DNA activate oncogenes? TIBS. 8:1983;190-191.
133. Thorsness P.E., Fox T.D. Escape of DNA from mitochondria to the nucleus in Saccharomyces cerevisiae. Nature. 346:1990;376-379.
134. Maximo V., Sobrinho-Simões M. J. Pathol. 192:2000;561-562.